The Liver Institute of Virginia has expanded from the campus of Bon Secours Mary Immaculate Hospital in Newport News, Virginia to open a second office at Bon Secours St. Mary’s Hospital in Richmond, Virginia. This expansion brings our world-renowned liver disease treatment specialist, Dr. Mitchell Shiffman, and his expert team to meet the needs of Richmond’s growing population.
Over the past months, the city of Newport News and the Hampton Roads community have benefited greatly from superior quality and the variety of liver disease treatment services offered by Dr. Shiffman and the Liver Institute of Virginia. Bon Secours was exited to expand this level of excellent health care with the opening of the Liver Institute’s second office at St. Mary’s Hospital in Richmond.
Services within the new office are providing comprehensive liver disease care close to home for Richmond residents including:
- Hepatitis vaccinations.
Patients with chronic liver disease, especially liver cirrhosis, are at increased risk to develop severe liver failure and die if they develop acute viral hepatitis A or B. The Liver Institute of Virginia recommends that all patients with chronic liver disease be vaccinated against viral hepatitis A and B.
- Pre-transplantation care and coordination.
The liver disease specialists at the Liver Institute of Virginia provide care before and following liver transplantation. This means that patients in Newport News and Richmond do not have to travel long distances for care at faraway liver transplant centers.
- Management of chronic liver disease and liver disease symptoms.
Dr. Shiffman and his team are experienced in treating all diseases and conditions of the liver, this includes treatment for all forms of chronic viral hepatitis, fatty liver disease, liver cirrhosis and its complications, and hepatocellular carcinoma.
- Clinical trials.
The Liver Institute of Virginia offers patients the opportunity to participate in a variety of clinical trials (for conditions such as Chronic Hepatitis C Virus, Hepatitis B Virus, and Non Alcoholic Steatohepatitis (or NASH)) to receive new and potentially highly effective medications that are not currently available to the general public.
About Dr. Mitchell Shiffman
The Liver Institute of Virginia is led by Dr. Mitchell Shiffman. Dr. Shiffman holds a Bachelor of Arts from State University of New York at Buffalo, a Master of Science in physiology from the University of New Mexico School of Medicine in Albuquerque, N.M. and his Doctor of Medicine from State University of New York Upstate Medical Center in Syracuse, N.Y. He completed his internship and residency in internal medicine and fellowship training in gastroenterology and hepatology at the Medical College of Virginia Hospitals in Richmond, VA. Dr. Shiffman is a member of many professional organizations including: the American College of Gastroenterology, American College of Physicians, the American Gastroenterological Association, American Society for the Study of Liver Diseases, American Society of Transplantation, European Association for the Study of the Liver, International Liver Transplantation Society, Richmond Academy of Medicine, Virginia Medical Society and the Virginia Gastrointestinal Society. He was a member of the Board of Trustees with the American College of Gastroenterology from 2003-2009. Dr. Shiffman was recently named one of the Best Doctors in America® in a peer-reviewed survey, which ranks him in the top five percent of specialists in the United States.